OncoTartis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

OncoTartis General Information

Description

Developer of anti-cancer drugs designed to help patients recover from acute leukemia. The company's drug development approach is designed to develop small molecules for the treatment of malignancies originating from specific tissues that are either non-essential for the general viability of mammalian organisms or can be effectively replaced, enabling patients to have access to novel therapies for the treatment of cancer and white cell diseases.

Contact Information

Website
www.oncotartis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 640 Ellicott Street
  • Suite 480
  • Buffalo, NY 14203
  • United States
+1 (716)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 640 Ellicott Street
  • Suite 480
  • Buffalo, NY 14203
  • United States
+1 (716)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTartis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Clinical Trials - Phase 1
5. Later Stage VC 11-Dec-2017 Completed Clinical Trials - Phase 1
4. Grant 07-Jun-2017 Completed Generating Revenue
3. Grant Completed Generating Revenue
2. Later Stage VC (Series B) 01-Jul-2016 $1.85M $8.25M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Feb-2011 $6.4M $6.4M Completed Generating Revenue
To view OncoTartis’s complete valuation and funding history, request access »

OncoTartis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of anti-cancer drugs designed to help patients recover from acute leukemia. The company's drug development app
Drug Discovery
Buffalo, NY

Gaithersburg, MD
 

New York, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoTartis Competitors (47)

One of OncoTartis’s 47 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD
Innovimmune Biotherapeutics Accelerator/Incubator Backed New York, NY
Light Chain Bioscience Formerly PE-Backed Geneva, Switzerland
SystImmune Venture Capital-Backed Redmond, WA
Loxo Oncology Formerly VC-backed Stamford, CT
You’re viewing 5 of 47 competitors. Get the full list »

OncoTartis Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • Pending

  • Expiring in next 12 mo

OncoTartis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014369926-A1 Benzamide and nicotinamide compounds and methods of using same Active 24-Dec-2013
AU-2014369926-B2 Benzamide and nicotinamide compounds and methods of using same Inactive 24-Dec-2013
AU-2019250170-A1 Benzamide and nicotinamide compounds and methods of using same Active 24-Dec-2013
AU-2019250170-B2 Benzamide and nicotinamide compounds and methods of using same Inactive 24-Dec-2013
CA-2933632-A1 Benzamide and nicotinamide compounds and methods of using same Active 24-Dec-2013 C07D471/04
To view OncoTartis’s complete patent history, request access »

OncoTartis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pharmstandard (Pharmaceuticals) Corporation Minority
Startup Village Government
Skolkovo Foundation Limited Partner
To view OncoTartis’s complete investors history, request access »

Ready to get started?

Request a free trial

OncoTartis FAQs

  • When was OncoTartis founded?

    OncoTartis was founded in 2011.

  • Where is OncoTartis headquartered?

    OncoTartis is headquartered in Buffalo, NY.

  • What industry is OncoTartis in?

    OncoTartis’s primary industry is Drug Discovery.

  • Is OncoTartis a private or public company?

    OncoTartis is a Private company.

  • What is OncoTartis’s current revenue?

    The current revenue for OncoTartis is .

  • How much funding has OncoTartis raised over time?

    OncoTartis has raised $14.2M.

  • Who are OncoTartis’s investors?

    Pharmstandard (Pharmaceuticals), Startup Village, and Skolkovo Foundation have invested in OncoTartis.

  • Who are OncoTartis’s competitors?

    NexImmune, Innovimmune Biotherapeutics, Light Chain Bioscience, SystImmune, and Loxo Oncology are some of the 47 competitors of OncoTartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »